Related Experiment Video

Updated: Aug 17, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Potential new therapies for the treatment of acute pancreatitis

W Denham1, J Norman

  • 1Department of Surgery, MDC 16, University of South Florida, 12901 Bruce B. Downs Blvd, Tampa, FL 33612, USA. edenham@com1.med.usf.edu

Expert Opinion on Investigational Drugs
|July 5, 2005
PubMed

Insights

Acute pancreatitis treatment lacks progress due to poor understanding of its intracellular events and inflammatory mediators. New therapies targeting key mediators like interleukin-1 beta show promise for effective treatment.

Area of Science:

  • Gastroenterology and Immunology
  • Pathophysiology of Inflammatory Diseases

Background:

  • Acute pancreatitis treatment has seen minimal advancement over 50 years.
  • Understanding of initial intracellular events and disease progression mediators is limited.
  • Systemic inflammation and distant organ failure mechanisms in pancreatitis are poorly understood.

Purpose of the Study:

  • To review the current understanding of acute pancreatitis pathophysiology.
  • To highlight the role of specific inflammatory mediators in disease progression.
  • To explore the potential for novel therapies targeting these mediators.

Main Methods:

  • Review of recent advances in pancreatitis pathophysiology.
  • Focus on the role of inflammatory mediators such as interleukin-1 beta, tumor necrosis factor alpha, and platelet-activating factor.
  • Examination of ongoing clinical trials for inflammatory mediator antagonists.

Main Results:

  • Inflammatory mediators like interleukin-1 beta, tumor necrosis factor alpha, and platelet-activating factor are implicated in pancreatitis progression.
  • Advances in understanding these mediators open avenues for targeted therapies.
  • Several inflammatory mediator antagonists are currently under human testing.

Conclusions:

  • A deeper understanding of pancreatitis pathophysiology is crucial for developing effective treatments.
  • Targeting specific inflammatory mediators offers a promising strategy for acute pancreatitis.
  • The development of specific therapies for acute pancreatitis may be imminent with ongoing research.

More Related Videos

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...